12 Cash-Rich Penny Stocks To Buy According To Hedge Funds
Shares priced under $5, commonly referred to as penny stocks, are a tempting bet for investors chasing big returns with minimal upfront investment.
Cytek Biosciences Inc. (CTKB)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Royce & Associates Chuck Royce | 565,819 | $2,268,934 | +21% | 0.02% |
| 2. | Bailard Inc Thomas Bailard | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $12.27 | 241,727 | Large Shareholder, Director | 13,381,054 | 2022-03-15 | Filing | |
| $12.35 | 342,143 | Large Shareholder, Director | 13,139,327 | 2022-03-14 | Filing | |
| $12.77 | 337,492 | Director | 12,797,184 | 2022-03-11 | Filing | |
| $12.95 | 256,992 | Director | 12,459,692 | 2022-03-10 | Filing | |
| $12.99 | 40,154 | Director | 12,202,700 | 2022-03-09 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $5.87 | 20,000 | 5,988,502 | 2024-04-19 | Filing | ||
| $7.01 | 400 | 6,008,502 | 2024-04-09 | Filing | ||
| $7.00 | 1,500 | 6,008,902 | 2024-04-09 | Filing | ||
| $6.71 | 20,000 | 6,010,402 | 2024-03-19 | Filing | ||
| $6.77 | 20,000 | 6,030,402 | 2024-03-18 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 18,069,282 | $72,457,819 | 0% | |
| 2. | 9,622,008 | $38,584,252 | 0% | |
| 3. | 1,158,001 | $4,643,584 | 0% | |
| 4. | 1,104,889 | $4,430,605 | 0% | |
| 5. | 845,405 | $3,390,074 | 0.22% |
News See All
Cytek Biosciences, Inc. (NASDAQ:CTKB) Q4 2024 Earnings Call Transcript
Operator: Thank you for standing by, and good day, everyone. My name is RG, and I will be your conference operator today.
Cytek Biosciences, Inc. (NASDAQ:CTKB) Q3 2024 Earnings Call Transcript
Operator: Thank you for standing by. At this time, I'd like to welcome everyone to the Cytek Biosciences' Third Quarter 2024 Earnings Conference Call.
Cytek Biosciences, Inc. (NASDAQ:CTKB) Q2 2024 Earnings Call Transcript
Operator: Thank you for standing by. My name is Luella, and I will be your conference operator today.
Cytek Biosciences, Inc. (NASDAQ:CTKB) Q1 2024 Earnings Call Transcript
Operator: Thank you for standing by. My name is Liz, and I'll be your conference operator today.
Cytek Biosciences, Inc. (NASDAQ:CTKB) Q4 2023 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to the Cytek Biosciences Fourth Quarter 2023 Earnings Conference Call.
Cytek Biosciences, Inc. (NASDAQ:CTKB) Q3 2023 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to the Cytek Biosciences Third Quarter 2023 Earnings Conference Call.
Hedge Fund and Insider Trading News: Steve Cohen, Cathie Wood, Caledonia Investments, Vapotherm Inc (VAPO), Inhibrx, Inc. (INBX), and More
The cryptocurrency industry eagerly awaits the next decision from the Securities and Exchange Commission after a U.S. court ruling a week ago regarding Grayscale Investments (GBTC).
Cytek Biosciences, Inc. (NASDAQ:CTKB) Q2 2023 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Cytek Biosciences Second Quarter 2023 Earnings Conference Call.
What Makes RGA Investments Hold Cytek Biosciences (CTKB)?
Investment management company RGA Investment Advisors recently released its first-quarter 2023 investor letter. A copy of the same can be downloaded here.
Billionaire Hedge Funds
